View New Articles By
Yung S. Lie, PhD, President and CEO of Damon Runyon Cancer Research Foundation, sat down with Denver Frederick, host of “The Business of Giving” on AM 970 The Answer WNYM in New York City, to discuss the history and strategy of the organization.
For the ninth year in a row, Damon Runyon has earned a 4-star rating from Charity Navigator for “demonstrating strong financial health and commitment to accountability and transparency.”
The warnings to use sunscreen are very real -- skin is the largest organ of the body and the most vulnerable to DNA damage caused by the sun’s ultraviolet rays. Basal cell carcinoma (BCC), a form of skin cancer, is the most common cancer in the United States with 3 million cases diagnosed annually. These cancers tend to grow slowly, usually developing on sun-exposed areas such as the head and neck, and treatment involves surgically removing the tumor. Usually this doesn’t present complications, but some individuals develop frequent recurrences of BCC that require multiple painful surgeries and scars.
Fifteen brilliant scientists from across the country were named Damon Runyon Fellows. The recipients of this prestigious, four-year award are outstanding postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators. The Fellowship encourages the nation's most promising young scientists to pursue careers in cancer research by providing them with independent funding ($231,000 total) to work on creative, high-risk projects.
The Damon Runyon Cancer Research Foundation has named four outstanding young scientists as recipients of the prestigious Damon Runyon-Sohn Pediatric Cancer Fellowship Award, committing nearly $1 million to help address a critical shortage of funding for pediatric cancer research.
For the past eight years, the Illini 4000 has spent their summers biking across the country to raise awareness and funds for cancer research. These students from the University of Illinois-Urbana began this year’s road trip in New York City on May 18. They will traverse more than 4,000 miles, battling weather and rough terrain, wrapping up August 3 at the Golden Gate Bridge in San Francisco.
When Bruce W. Stillman, PhD (Damon Runyon Fellow ’79 - ’81), arrived at Cold Spring Harbor Laboratory from his native Australia, he expected to stay for two years — the length of his Damon Runyon award. Forty years later, Dr. Stillman is the President and CEO of the renowned institution.
The Damon Runyon Cancer Research Foundation named five new Damon Runyon Clinical Investigators at its spring 2019 Clinical Investigator Award Committee review. The recipients of this prestigious three-year award are outstanding early career physician-scientists conducting patient-oriented cancer research at major research centers under the mentorship of the nation’s leading scientists and clinicians. Each will receive $600,000 to support the development of his/her project, selected for its potential to impact cancer diagnosis, prevention and treatment. Damon Runyon also repays medical school debt up to $100,000 still owed by the awardee.
The cancer was spreading into her spine, despite the intensive chemotherapy she had already endured. But Denise refused to give up. A single mom and real estate agent, she was determined to see her son graduate from college.
James E. Rothman, PhD, received the 2013 Nobel Prize in Physiology or Medicine for work he began when he was a Damon Runyon Fellow from 1976 to 1978. His research demonstrated, for the first time, how tiny sac-like structures called vesicles help transport substances to different places inside the cell and send molecules from the cell's surface as signals to other cells in the body.
CONNECT
1.877.7CANCER
info@damonrunyon.org
One Exchange Plaza
55 Broadway, Suite 302
New York, NY 10006
